United States biobanks market is expected to grow at a significant rate during the forecast period. Growing need to store and preserve the biological samples such as nucleic acids, tissues, blood which are in demand for research activities for advancements in biomedical research and identify disease-relevant biomarkers. The rise in the number of research activities is considered the major driver for the forecast period. An increase in investments and funding made by the leading authorities and market players to advance the sectors such as regenerative medicine, cell & gene therapy, stem cell therapeutics is promoting the scope of research activities which in turn is accelerating the market growth. The surge in the adoption of cord blood banking techniques by healthcare facilities offers several benefits such as more people can receive stem cells than received through the bone marrow and this process is less complicated and painful for the donor which in turn is fostering the growth of the biobanks market. Biobanks play a significant role to maintain and update the age demographic databases. The rising demand for personalized medicine as it is considered more effective and provides better results is contributing to the surge in the biobanks market growth.

United States biobanks market is segmented into type, ownership, product, specimen type, application, end user, regional distribution, and company. Based on product, the market can be divided into equipment & consumables, media, software & services. The equipment & consumables product segment is expected to hold a major market share in the forecast period. The rise in the number of biobanks is aiding to increase the capacity to store a large number of biosamples is increasing the demand for biobanking devices which in turn is accelerating the market growth.

The major players operating in the United States biobanks market are Thermo Fisher Scientific Inc., Hamilton Company, Brooks Automation, Inc., VWR Corporation, LLC, Promega Corporation, Becton, Dickinson, and Company, RUCDR Infinite Biologics, LabVantage Solutions Inc., US Biolab Corporation, Inc., ProteoGenex, Inc., Cureline, Inc., Bay Biosciences LLC, Geneticist Inc, BioLifeSolutions Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth of the market size of United States biobanks market from 2016 to 2019.
  • To estimate and forecast the market size of United States biobanks market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast United States biobanks market based on type, ownership, product, specimen type, application, end user, regional distribution, and company.
  • To identify dominant region or segment in the United States biobanks.
  • To identify drivers and challenges for United States biobanks market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States biobanks market.
  • To identify and analyze the profile of leading players operating in United States biobanks market.
  • To identify key sustainable strategies adopted by market players in United States biobanks market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of United States biobanks market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Biobank service provider companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to biobanks market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States biobanks market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United States Biobanks Market, By Type:

    • Population Based Biobanks
    • Disease Oriented Biobanks
  • United States Biobanks Market, By Ownership:
    • National/regional agency
    • Non-profit Organization
    • Universities
    • Private Organization
  • United States Biobanks Market, By Product:
    • Equipment & Consumables
    • Media
    • Software & Services
  • United States Biobanks Market, By Specimen Type:
    • Blood Products
    • Solid Tissue
    • Cell Lines
    • Nucleic Acid
    • Others
  • United States Biobanks Market, By Application:
    • Therapeutic
    • Research
  • United States Biobanks Market, By End User:
    • Academic Institutes
    • Pharma & Biotech Companies
    • Others
  • United States Biobanks Market, By Region:
    • South
    • West
    • Mid-West
    • North East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States biobanks market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United States Biobanks Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Biobanks Market

4.    Voice of Customer

5.    Executive Summary

6.    United States Biobanks Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Population Based Biobanks v/s Disease Oriented Biobanks)

6.2.2.     By Ownership (National/regional agency, Non-profit Organization, Universities, and Private Organization)

6.2.3.     By Product (Equipment & Consumables, Media, Software & Services)

6.2.4.     By Specimen Type (Blood Products, Solid Tissue, Cell Lines, Nucleic Acid, Others)

6.2.5.     By Application (Therapeutic v/s Research)

6.2.6.     By End User (Academic Institutes, and Pharma & Biotech Companies, Others)

6.2.7.     By Company (2020)

6.2.8.     By Region

6.3.  Product Market Map

7.    United States Population Based Biobanks Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Ownership

7.2.2.     By Specimen Type

7.2.3.     By Application

7.2.4.     By End User

8.    United States Disease Oriented Biobanks Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Ownership

8.2.2.     By Specimen Type

8.2.3.     By Application

8.2.4.     By End User

8.2.5.     By Fixation

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  United States Economic Profile

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Company Profiles

13.2.1.  Thermo Fisher Scientific Inc.

13.2.2.  Hamilton Company

13.2.3.  Brooks Automation, Inc.

13.2.4.  VWR Corporation, LLC

13.2.5.  Promega Corporation

13.2.6.  Becton, Dickinson, and Company

13.2.7.  RUCDR Infinite Biologics

13.2.8.  LabVantage Solutions Inc.

13.2.9.  US Biolab Corporation, Inc.

13.2.10.                ProteoGenex, Inc.

13.2.11.                Cureline, Inc.

13.2.12.                Bay Biosciences LLC

13.2.13.                Geneticist Inc

13.2.14.                BioLifeSolutions Inc.

13.2.15.                All of Us- Biobank

14.  Strategic Recommendations

15.  About Us & Disclaimer